About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Illinois | 1,017 Studies

Clinical Trials Breast CancerIllinois

Breast Cancer Clinical Trials in Illinois

Find 1,017 clinical trials for breast cancer near Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 581-600 of 1,017 trials

RecruitingAlcohol, Breast Cancer, and MetabolismAlcohol consumption, even at low levels, has been associated with increased breast cancer risk, but the biological mechanisms underlying this relationship remain unclear.NCT07779967·Urbana, Illinois Active not recruitingMonitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN StudyThis phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay…NCT05568472·Kingman, Arizona and 489 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedDocetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004175·Stanford, California and 3 others

UnknownBreast Cancer Liquid Biopsy TrialThe purpose of this study is to continue to develop a liquid biopsy (minimally invasive blood test) that can be used to confirm if breast cancer has spread throughout the body and…NCT04962529·Hollywood, Florida and 7 others

TerminatedPrevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast CancerThe investigators will study the effect of 12 months of SDG (Brevail) vs placebo on women at increased risk for development of breast cancer.NCT01276704·Little Rock, Arkansas and 6 others

CompletedA Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast CancerThis is an international, multisite, open-label, Phase 1b/2 study, to confirm safety and efficacy of samuraciclib in combination with elacestrant in adult participants with…NCT05963997·Chicago, Illinois and 22 others

Active not recruitingTesting MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerThis randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer.NCT02954874·Birmingham, Alabama and 918 others

CompletedHarvest of CTCs From MBC Patients Using the Parsortix™ PC1 SystemThe purpose of this clinical study is to demonstrate that the Parsortix™ PC1 system enables the capture and harvest of circulating tumor cells (CTCs) from the peripheral blood of…NCT03427450·Los Angeles, California and 3 others

CompletedEGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast CancerRATIONALE: Chemotherapy may cause memory loss, attention loss, and other problems that make it difficult for patients to think clearly.NCT00046891·Scottsdale, Arizona and 174 others

CompletedMRI and Mammography Before Surgery in Patients With Stage I-II Breast CancerThe purpose of this study is to test whether patients undergoing a breast MRI (magnetic resonance imaging) before breast surgery will have better results after the surgery.NCT01805076·Gilbert, Arizona and 178 others

Active not recruitingClinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or PlaceboThe main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug, atezolizumab, is…NCT03281954·Mobile, Alabama and 216 others

CompletedBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerThis phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer.NCT03180294·Anaheim, California and 361 others

TerminatedPivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast CancerThis is a phase 3, multicenter, open-label, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability of intravenous balixafortide given…NCT03786094·Fresno, California and 87 others

CompletedStudy of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast CancerA randomized multi-arm study evaluating the efficacy and safety of nivolumab versus placebo in combination with neoadjuvant (pre-surgery) chemotherapy and adjuvant (post-surgery)…NCT04109066·Mobile, Alabama and 239 others

CompletedTrial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersThis is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with selected chemotherapy agents in…NCT02892123·Birmingham, Alabama and 16 others

UnknownOral CDB-4124 vs. Placebo in Stage I-II Primary Breast CancerThe purpose of this study is to determine whether or not the medication that blocks the effects of the hormone progesterone (CDB-4124 or Proellex) will decrease the growth rate of…NCT01800422·Chicago, Illinois

RecruitingSaruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerThe primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients with BRCA1, BRCA2…NCT06380751·Gilbert, Arizona and 305 others

CompletedA Study of Serum Folate Levels in Patients Treated With OlaparibThis is a study investigating folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib to treat their advanced ovarian or breast cancer.NCT04024254·Chicago, Illinois

CompletedLapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerThis open label study was designed to evaluate Lapatinib effect on incidence of brain metastases in ErbB2 (HER2) positive metastatic breast cancer patients exposed to prior…NCT00820222·Goodyear, Arizona and 163 others

TerminatedA Study to Investigate LYL797 in Adults With Solid TumorsThis study will evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer…NCT05274451·Scottsdale, Arizona and 17 others

PreviousPage 30 of 51Next

Other Conditions in Illinois

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma